Effect of Combination Therapy with Alpha-Lipoic Acid on the Fractalkine Level in Patients with Coronary Artery Disease and Type 2 Diabetes Mellitus
Journal Title: Міжнародний ендокринологічний журнал - Year 2016, Vol 7, Issue 79
Abstract
Background. The aim of research — to assess the fractalkine levels in patients with coronary artery disease (CAD), depending on the presence of type 2 diabetes mellitus (DM) and the nature of coronary artery lesions before treatment and during the standard and combination therapy with the addition of alpha-lipoic acid. Materials and methods. We have examined 131 patients with CAD (89 men and 42 women), mean age of them was 59.60 ± 9.11 years. The control group consisted of 20 apparently healthy volunteers of the same age and sex. Depending on the presence of type 2 DM, patients with CAD were divided into 2 groups: the first group (n = 70) — patients with concomitant type 2 DM, the second group (n = 61) — patients with CAD and without concomitant type 2 DM. All patients were performed coronary angiography to verify the diagnosis of CAD. All patients, depending on the nature of coronary artery lesions and therapy, were divided into 2 subgroups — subgroup IA (standard therapy) and the subgroup IB (combination therapy). All patients were evaluated fractalkine levels before therapy and after 3 months of treatment. Results. The study found that patients with CAD, both with concomitant type 2 DM or without it, had significantly increased levels of fractalkine compared with the control group (p < 0.05). When comparing treatment regimens, it was found that in the subgroup of standard therapy, fractalkine average level before treatment was 485.07 ± 106.55 pg/ml, and after 3 months of therapy — 444.08 ± 99.86 pg/ml, while there was no significant difference between baseline value and the value reached after 3 months (p = 0.08), although there was a trend to reduce the level of this indicator. Patients from IB subgroup (n = 105), who received combination therapy, had a significant trend to reduce the fractalkine level in 3 months as compared to the initial value before therapy (510.49 ± 103.95 pg/ml vs 575.56 ± 123.86 pg/ml; p = 0.00001). The relative reduction in fractalkine level in the subgroup IA was 8.45 %, in the subgroup IB — 11.3 %. Conclusions. The study results demonstrate the impact of endothelial dysfunction on the development and progression of atherosclerosis, especially in patients with concomitant type 2 DM. Applying alpha-lipoic acid in combination therapy schemes contributes to a significant reduction in fractalkine levels, and, thus, leads to a decrease in endothelial dysfunction and, as a result, to the possible improvement of prognosis in this group of patients.
Authors and Affiliations
L. V. Zhuravlyova, N. A. Lopina
Keywords
Related Articles
- EP ID EP177638
- DOI 10.22141/2224-0721.7.79.2016.86422
- Views 42
- Downloads 0
Draft Concept of the State Target Social Program «Diabetes Mellitus for the Period until 2018»
.
The Meaning of Using «The Quality of Life Assessment of Growth Hormone Deficiency in Adults» Questionnaire in Patients with Non-Functional Pituitary Adenomas and Various Tumors of Chiasmosellar Area in Pre- and Postoperative Period
The authors have examined 136 patients with growth hormone deficiency (GHD) of various origins (pituitary tumors and ischemic heart disease — comparison group). The investigation of the quality of life on the basis of GH...
Features of Mineral Metabolism Disorders in Patients with ultinodular Goiter after Thyroidectomy
The features of calcium, phosphorus, parathyroid hormone and vitamin D indexes in patients with multinodular non-toxic goiter after thyroidectomy are presented in the article. It is found that age over 60 years, greater...
Adaptive Capacity and Features of Energy Metabolism in Patients with Diabetes Mellitus Type 2
The study of the processes of adaptation and characteristics of energy metabolism in patients with diabetes mellitus (DM) type 2 can serve as a basis for determining their role in the pathogenesis of this disease and con...
Insulin and leptin levels in type 1 and type 2 diabetes patients with diabetes-associated osteoarthritis
Background. Joint damage in patients with diabetes mellitus is a common complication and is associated with degenerative dystrophic changes in the periarticular structures. The purpose of our work was to study insulin an...